1.42
price down icon0.66%   -0.01
 
loading
Compugen Ltd stock is traded at $1.42, with a volume of 49,686. It is down -0.66% in the last 24 hours and down -16.93% over the past month. Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
See More
Previous Close:
$1.43
Open:
$1.43
24h Volume:
49,686
Relative Volume:
0.21
Market Cap:
$128.93M
Revenue:
-
Net Income/Loss:
$1.60M
P/E Ratio:
-3.55
EPS:
-0.4
Net Cash Flow:
$-62.91M
1W Performance:
-4.66%
1M Performance:
-16.93%
6M Performance:
-23.63%
1Y Performance:
+114.61%
1-Day Range:
Value
$1.41
$1.44
1-Week Range:
Value
$1.35
$1.50
52-Week Range:
Value
$0.62
$3.0301

Compugen Ltd Stock (CGEN) Company Profile

Name
Name
Compugen Ltd
Name
Phone
-
Name
Address
-
Name
Employee
68
Name
Twitter
@CompugenLtd
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
CGEN's Discussions on Twitter

Compare CGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
CGEN 1.42 128.93M 0 1.60M -62.91M -0.40
VRTX 446.50 115.74B 10.63B -479.80M -1.35B 13.33
REGN 739.88 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.80 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.97 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.80 24.49B 3.30B -501.07M 1.03B 11.54

Compugen Ltd Stock (CGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-05-22 Downgrade Jefferies Buy → Hold
May-26-20 Resumed JMP Securities Mkt Outperform
May-13-20 Initiated Stifel Buy
May-07-20 Initiated SVB Leerink Outperform
Apr-22-20 Initiated ROTH Capital Buy
Mar-24-20 Initiated SunTrust Buy
Jan-16-20 Initiated Cantor Fitzgerald Overweight
Mar-29-18 Initiated Oppenheimer Outperform
Feb-01-16 Resumed Oppenheimer Outperform
Oct-15-15 Initiated FBR Capital Outperform
Apr-23-15 Resumed Jefferies Buy
Apr-21-15 Initiated Oppenheimer Outperform
Feb-07-14 Initiated MLV & Co Buy
Dec-28-09 Reiterated Cantor Fitzgerald Buy
Jul-29-09 Initiated Cantor Fitzgerald Buy
View All

Compugen Ltd Stock (CGEN) Latest News

pulisher
Nov 16, 2024

Compugen Ltd. (NASDAQ:CGEN) Short Interest Down 18.1% in October - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Compugen (CGEN) Stock Declines Amidst Industry Downtrend - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Compugen Ltd. (NASDAQ:CGEN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Compugen Ltd (CGEN) Q3 2024 Earnings Call Highlights: Promising Developments and Strategic ... By GuruFocus - Investing.com Canada

Nov 13, 2024
pulisher
Nov 12, 2024

Compugen Reports Strong Q3 2024 Results and Progress - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Compugen: Q3 Earnings Snapshot - The Washington Post

Nov 12, 2024
pulisher
Nov 12, 2024

Compugen (CGEN) Q3 Earnings and Revenues Lag Estimates - Yahoo Canada Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Compugen earnings beat by $0.11, revenue topped estimates - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Compugen Surges with $17.1M Revenue, Reports Breakthrough Cancer Drug Progress | CGEN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Compugen to Participate in Stifel 2024 Healthcare Conference - StockTitan

Nov 11, 2024
pulisher
Nov 10, 2024

Compugen (CGEN) to Release Quarterly Earnings on Tuesday - Defense World

Nov 10, 2024
pulisher
Nov 08, 2024

Compugen (NASDAQ:CGEN) shareholder returns have been stellar, earning 204% in 1 year - Simply Wall St

Nov 08, 2024
pulisher
Nov 05, 2024

Compugen Showcases Promising Data on Ovarian Cancer Therapy - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Compugen's Cancer Drug Combo Shows 17.4% Response Rate in Ovarian Cancer Trial | CGEN Stock News - StockTitan

Nov 05, 2024
pulisher
Oct 29, 2024

Short Interest in Compugen Ltd. (NASDAQ:CGEN) Decreases By 17.1% - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - cnhinews.com

Oct 29, 2024
pulisher
Oct 29, 2024

Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 | CGEN Stock News - StockTitan

Oct 29, 2024
pulisher
Oct 24, 2024

Compugen Gears Up to Report Q3 Earnings: Here's What to Expect - Yahoo Finance

Oct 24, 2024
pulisher
Oct 07, 2024

Compugen to Present New Clinical Data at SITC 2024 - StockTitan

Oct 07, 2024
pulisher
Oct 03, 2024

Compugen Ltd. (NASDAQ:CGEN) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 03, 2024
pulisher
Sep 30, 2024

Compugen’s stock rockets on deal with Gilead for anti-tumor drug - MSN

Sep 30, 2024
pulisher
Sep 29, 2024

Compugen Ltd. (NASDAQ:CGEN) Sees Large Growth in Short Interest - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

CompoSecure Inc (CMPO) Analyst Thoughts: How High Can It Go? - Stocks Register

Sep 28, 2024
pulisher
Sep 19, 2024

Compugen Ltd. (NASDAQ:CGEN) Short Interest Update - Defense World

Sep 19, 2024
pulisher
Sep 13, 2024

Compugen Shareholders Approve All Proposals - TipRanks

Sep 13, 2024
pulisher
Sep 11, 2024

Compugen (CGEN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance

Sep 11, 2024
pulisher
Sep 09, 2024

Compugen to Present at Single Cell Genomics 2024 Conference - StockTitan

Sep 09, 2024
pulisher
Sep 06, 2024

Compugen Ltd (CGEN)’s Market Momentum: Closing Strong at 1.82, Down -7.61 - The Dwinnex

Sep 06, 2024
pulisher
Sep 06, 2024

Compugen Ltd’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Sep 06, 2024
pulisher
Sep 04, 2024

Compugen Ltd (CGEN) shows promising results - US Post News

Sep 04, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Buys Shares of 221,900 Compugen Ltd. (NASDAQ:CGEN) - Defense World

Sep 02, 2024
pulisher
Aug 29, 2024

CGENCompugen Ltd Latest Stock News & Market Updates - StockTitan

Aug 29, 2024
pulisher
Aug 29, 2024

Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Aug 29, 2024
pulisher
Aug 26, 2024

Can Compugen (CGEN) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Aug 26, 2024
pulisher
Aug 22, 2024

Investors Aren't Buying Compugen Ltd.'s (NASDAQ:CGEN) Revenues - Simply Wall St

Aug 22, 2024
pulisher
Aug 15, 2024

Compugen (NASDAQ:CGEN) Lifted to “Buy” at StockNews.com - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

Compugen (NASDAQ:CGEN) Lifted to Buy at StockNews.com - MarketBeat

Aug 15, 2024
pulisher
Aug 11, 2024

Party Time: Brokers Just Made Major Increases To Their Compugen Ltd. (NASDAQ:CGEN) Earnings Forecasts - Yahoo Finance

Aug 11, 2024
pulisher
Aug 10, 2024

Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 10, 2024
pulisher
Aug 08, 2024

Compugen (NASDAQ:CGEN) Downgraded by StockNews.com to Hold - Defense World

Aug 08, 2024
pulisher
Aug 07, 2024

Compugen Ltd. (NASDAQ:CGEN): When Will It Breakeven? - Yahoo Finance

Aug 07, 2024
pulisher
Aug 07, 2024

Compugen: Q2 Earnings Snapshot - San Antonio Express-News

Aug 07, 2024
pulisher
Aug 06, 2024

Compugen Ltd reports results for the quarter ended in JanuaryEarnings Summary - TradingView

Aug 06, 2024

Compugen Ltd Stock (CGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):